Clinical Trials
0
Active:0
Completed:0
Trial Phases
0 Phases
Drug Approvals
87
NMPA:65
EMA:11
SFDA:8
+1 more agencies
Drug Approvals
Recombinant Follitropin Beta Injection
- Product Name
- 普丽康
- Approval Number
- 国药准字SJ20150066
- Approval Date
- Aug 21, 2024
NMPA
Recombinant Follitropin Beta Injection
- Product Name
- 普丽康
- Approval Number
- 国药准字SJ20150065
- Approval Date
- Aug 21, 2024
NMPA
Mirtazapine Orally Disintegrating Tablets
- Product Name
- 米氮平口腔崩解片
- Approval Number
- 国药准字HJ20160688
- Approval Date
- Dec 18, 2023
NMPA
Mirtazapine Orally Disintegrating Tablets
- Product Name
- 米氮平口腔崩解片
- Approval Number
- 国药准字HJ20160677
- Approval Date
- Dec 18, 2023
NMPA
Mirtazapine Orally Disintegrating Tablets
- Product Name
- 米氮平口腔崩解片
- Approval Number
- 国药准字HJ20160676
- Approval Date
- Dec 18, 2023
NMPA
Ezetimibe and Atorvastatin Calcium Tablets（Ⅱ）
- Product Name
- 依折麦布阿托伐他汀钙片(Ⅱ)
- Approval Number
- 国药准字HJ20230110
- Approval Date
- Sep 12, 2023
NMPA
Ezetimibe and Atorvastatin Calcium Tablets（Ⅰ）
- Product Name
- 依折麦布阿托伐他汀钙片(Ⅰ)
- Approval Number
- 国药准字HJ20230109
- Approval Date
- Sep 12, 2023
NMPA
- Prev
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- Next
Clinical Trials
No trials found
News
No news found